Table 3. Independent risk factors of clopidogrel resistance in MS patients.

Variables	β	P	OR	95%CI
Sex (Gender)	0.215	0.629	1.240	0.51–2.965
Age (> 65 yr)	1.113	0.002	1.483	1.047–6.248
Hypertension	−0.368	0.532	0.692	0.21–2.197
Obesity	1.283	0.018	3.608	1.241–10.488
Hypertriglyceridemia	−0.232	0.580	0.793	0.34–0.805
Low HDL	0.443	0.286	0.286	0.690–3.510
High fasting plasma glucose	0.999	0.019	2.717	1.176–6.277
Hyperuricemia	0.949	0.030	2.583	1.095–6.094

Low HDL: cholesterol < 40 mg/dL (1.03 mmol/L) in men or < 50 mg/dL (1.29 mmol/L) in women; high fasting glucose: fasting plasma glucose ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed with type 2 diabetes; hyperuricemia: uric acid > 420 µmol/L. HDL: high-density Lipoprotein; MS: metabolic syndrome.